Monoclonal Antibodies Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Monoclonal Antibodies stocks.

Monoclonal Antibodies Stocks Recent News

Date Stock Title
Nov 22 LXRX Lexicon Pharmaceuticals to Cut 60% of Workforce
Nov 22 LXRX Lexicon falls on restructuring program
Nov 22 BIIB Goldman Sachs: Biogen Inc. (BIIB) Is A Top Growth Investor Stock
Nov 22 LXRX Lexicon to Reposition as Clinical Development-Focused Company Following Regulatory Update From FDA
Nov 22 BIIB Biogen price target lowered to $207 from $251 at Mizuho
Nov 21 GMAB Why Is Genmab A/S (GMAB) Among the Worst Performing Biotech Stocks in 2024?
Nov 20 LXRX Lexicon Appoints Ivan H. Cheung to Board of Directors
Nov 20 BIIB Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside
Nov 20 BIIB Biogen Inc. (BIIB): Among the Best Genomics Stocks to Buy Right Now
Nov 19 REGN Regeneron Pharmaceuticals, Inc. (REGN): Among the Best Genomics Stocks to Buy Right Now
Nov 19 AFMD Is Affimed N.V. (AFMD) the Best German Stock to Buy Now?
Nov 19 REGN Regeneron Pharmaceuticals, Inc. (REGN) Jefferies London Healthcare Conference (Transcript)
Nov 19 REGN Regeneron: The Biotech Stock To Buy Now
Nov 19 BIIB Biogen, UCB release phase 3 data on lupus candidate dapirolizumab
Nov 19 REGN Here’s Why Regeneron Pharmaceuticals (REGN) Declined in Q3
Nov 19 BIIB Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity
Nov 18 BNOX Bionomics files for $100M mixed securities shelf
Nov 18 REGN FDA Accepts SNY and REGN's Dupixent Re-Submitted sBLA for Urticaria
Nov 18 BIIB Biogen's Outlook Dims As Analyst Projects Flat Revenue Until 2026
Nov 18 BIIB Needham downgrades Biogen on slow growth of Alzheimer's drug
Monoclonal Antibodies

Monoclonal antibodies (mAb or moAb) are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). In contrast, polyclonal antibodies bind to multiple epitopes and are usually made by several different plasma cell (antibody secreting immune cell) lineages. Bispecific monoclonal antibodies can also be engineered, by increasing the therapeutic targets of one single monoclonal antibody to two epitopes.

Browse All Tags